Unité de Fabrication des Médicaments S.A (BVMT:UMED)
Tunisia flag Tunisia · Delayed Price · Currency is TND
9.10
0.00 (0.00%)
At close: Feb 3, 2026

BVMT:UMED Income Statement

Millions TND. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
153.79147.6813696.3684.591.04
Other Revenue
----0.01-
153.79147.6813696.3684.5191.04
Revenue Growth (YoY)
9.10%8.58%41.14%14.02%-7.17%-15.07%
Cost of Revenue
65.6566.8761.7246.838.2243.69
Gross Profit
88.1380.874.2949.5646.2947.35
Selling, General & Admin
21.1521.1119.7116.7715.4815.1
Other Operating Expenses
9.879.859.888.276.878.37
Operating Expenses
50.0547.4345.1835.9532.5534.03
Operating Income
38.0833.3729.1113.6113.7413.33
Interest Expense
-6.79-6.9-6.22-3.6-2.63-3.74
Interest & Investment Income
0.890.320.090.190.280.01
Currency Exchange Gain (Loss)
0.030.18-0.48-0.05-0.480.33
Other Non Operating Income (Expenses)
0.060.09-11.3-0.22-0.45-0.69
EBT Excluding Unusual Items
32.2827.0711.219.9410.479.23
Gain (Loss) on Sale of Assets
0.17-0.080.090.040.08
Asset Writedown
-0.15-0.1-0.3-0.2-0.08-0.04
Pretax Income
32.2926.9710.999.8310.439.27
Income Tax Expense
10.087.65.4521.722.29
Earnings From Continuing Operations
22.2219.375.557.838.76.98
Net Income
22.2219.375.557.838.76.98
Net Income to Common
22.2219.375.557.838.76.98
Net Income Growth
245.33%249.30%-29.17%-10.03%24.69%-60.55%
Shares Outstanding (Basic)
323232323232
Shares Outstanding (Diluted)
323232323232
EPS (Basic)
0.690.610.170.240.270.22
EPS (Diluted)
0.690.610.170.240.270.22
EPS Growth
245.33%249.31%-29.17%-10.03%24.69%-60.55%
Free Cash Flow
11.9310.5818.68-12.0715.130.08
Free Cash Flow Per Share
0.370.330.58-0.380.470.00
Dividend Per Share
0.5700.570-0.4690.406-
Dividend Growth
---15.52%--
Gross Margin
57.31%54.72%54.62%51.43%54.77%52.01%
Operating Margin
24.76%22.60%21.40%14.12%16.26%14.64%
Profit Margin
14.45%13.12%4.08%8.13%10.30%7.67%
Free Cash Flow Margin
7.76%7.16%13.73%-12.52%17.90%0.09%
EBITDA
48.0143.3939.1123.323.0222.79
EBITDA Margin
31.22%29.39%28.75%24.19%27.24%25.03%
D&A For EBITDA
9.9210.02109.699.279.46
EBIT
38.0833.3729.1113.6113.7413.33
EBIT Margin
24.76%22.60%21.40%14.12%16.26%14.64%
Effective Tax Rate
31.21%28.17%49.56%20.35%16.52%24.74%
Revenue as Reported
153.89147.87136.1596.6284.5591.07
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.